J. M. Reno

Cure of human carcinoma xenografts by a single dose of pretargeted yttrium-90 with negligible toxicity

Donald B. Axworthy, J. M. Reno, Mark D. Hylarides et al. · Proceedings of the National Academy of Sciences · 2000 · 230 citations

Medicine, Oncology, Pharmacology +17

Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer.

D. Scott Wilbur, S. W. HADLEY, Mark D. Hylarides et al. · PubMed · 1989 · 172 citations

Medicine, Oncology, Radiation Oncology +16

Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent.

Alan R. Fritzberg, Paul G. Abrams, Paul L. Beaumier et al. · Proceedings of the National Academy of Sciences · 1988 · 161 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmacology +17

Development and biologic evaluation of a kit for preformed chelate technetium-99m radiolabeling of an antibody Fab fragment using a diamide dimercaptide chelating agent.

S. Kasina, T. Nageswara Rao, A. Srinivasan et al. · PubMed · 1991 · 70 citations

Pharmacy, Biochemistry, Molecular Pharmaceutics +17

PRECLINICAL EVALUATION OF AN ANTI-TUMOR MONCLONAL ANTIBODY/ STREPTAVIDIN CONJUGATE FOR PRETARGETED 90Y RADIOIMMUNOTHERAPY IN A MOUSE XENOGRAFT MODEL

Donald B. Axworthy, Alan R. Fritzberg, Mark D. Hylarides et al. · Journal of Immunotherapy · 1994 · 45 citations

Medicine, Immunology, Oncology +16